{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:33:49Z","timestamp":1790278429230,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10753-013-9716-x","type":"journal-article","created":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T06:29:08Z","timestamp":1377930548000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Serdar","family":"Soydinc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Halil","family":"Turkbeyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcimen","family":"Soylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Fatih","family":"Goktepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Bilici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,1]]},"reference":[{"key":"9716_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0889-857X(05)70295-7","volume":"22","author":"EC LeRoy","year":"1996","unstructured":"LeRoy, E.C. 1996. Systemic sclerosis. A vascular perspective. Rheumatic Diseases Clinics of North America 22: 675\u2013694.","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"9716_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/08916939908994064","volume":"31","author":"MB Kahaleh","year":"1999","unstructured":"Kahaleh, M.B., and E.C. Leroy. 1999. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31: 195\u2013214.","journal-title":"Autoimmunity"},{"key":"9716_CR3","first-page":"19","volume":"22","author":"MB Kahaleh","year":"2004","unstructured":"Kahaleh, M.B. 2004. Vascular involvement in systemic sclerosis (SSc). Clinical and Experimental Rheumatology 22: 19\u201323.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"9716_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/mic.10.3-4.335.350","volume":"10","author":"AR Gear","year":"2003","unstructured":"Gear, A.R., and D. Camerini. 2003. Platelet chemokines and chemokine receptors: Linking hemostasis, inflammation, and host defense. Microcirculation 10: 335\u2013350.","journal-title":"Microcirculation"},{"key":"9716_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1046\/j.1538-7836.2003.00304.x","volume":"1","author":"AS Weyrich","year":"2003","unstructured":"Weyrich, A.S., S. Lindemann, and G.A. Zimmerman. 2003. The evolving role of platelets in inflammation. Journal of Thrombosis and Haemostasis 1: 1897\u20131905.","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"9716_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2141.1983.tb02109.x","volume":"54","author":"JF Martin","year":"1983","unstructured":"Martin, J.F., T. Shaw, J. Heggie, and D.G. Penington. 1983. Measurement of the density of human platelets and its relationship to volume. British Journal of Haematology 54: 337\u2013352.","journal-title":"British Journal of Haematology"},{"key":"9716_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","volume":"338","author":"JF Martin","year":"1991","unstructured":"Martin, J.F., P.M.W. Bath, and M.L. Burr. 1991. Influence of platelet size on outcome after myocardial infarction. Lancet 338: 1409\u20131411.","journal-title":"Lancet"},{"issue":"2","key":"9716_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2010.09.010","volume":"213","author":"JS Berger","year":"2010","unstructured":"Berger, J.S., L.H. Eraso, D. Xie, D. Sha, and E.R. Mohler 3rd. 2010. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999\u20132004. Atherosclerosis 213(2): 586\u2013591.","journal-title":"Atherosclerosis"},{"key":"9716_CR9","first-page":"105","volume":"4","author":"D Pattanaik","year":"2011","unstructured":"Pattanaik, D., M. Brown, and A.E. Postlethwaite. 2011. Vascular involvement in systemic sclerosis (scleroderma). Journal of Inflammation Research 4: 105\u2013125.","journal-title":"Journal of Inflammation Research"},{"key":"9716_CR10","first-page":"119","volume":"2","author":"LT Friedhoff","year":"1984","unstructured":"Friedhoff, L.T., J.R. Seibold, H.C. Kim, and K.S. Simester. 1984. Serotonin induced platelet aggregation in systemic sclerosis. Clinical and Experimental Rheumatology 2: 119\u2013123.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"9716_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","volume":"19","author":"AE Postlethwaite","year":"2007","unstructured":"Postlethwaite, A.E., and T.M. Chiang. 2007. Platelet contributions to the pathogenesis of systemic sclerosis. Current Opinion in Rheumatology 19: 574\u2013579.","journal-title":"Current Opinion in Rheumatology"},{"key":"9716_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi, A.T., T.A. Medsger, G.P. Rodnan, et al. 1980. Preliminary criteria for the classification of systemic sclerosis. Arthritis and Rheumatism 23: 581\u2013590.","journal-title":"Arthritis and Rheumatism"},{"key":"9716_CR13","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements, P., P. Lachenbruch, J. Seibold, et al. 1995. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. Journal of Rheumatology 22: 1281\u20131285.","journal-title":"Journal of Rheumatology"},{"key":"9716_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini, G., A. Della Rossa, S. Bombardieri, et al. 2001. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Annals of the Rheumatic Diseases 60: 592\u2013598.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9716_CR15","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger Jr., T.A., A.J. Silman, V.D. Steen, et al. 1999. A disease severity scale for systemic sclerosis: Development and testing. Journal of Rheumatology 26: 2159\u20132167.","journal-title":"Journal of Rheumatology"},{"key":"9716_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","volume":"61","author":"M Gawaz","year":"2004","unstructured":"Gawaz, M. 2004. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovascular Research 61: 498\u2013511.","journal-title":"Cardiovascular Research"},{"key":"9716_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1160\/TH03-07-0440","volume":"91","author":"E Anitua","year":"2004","unstructured":"Anitua, E., I. Andia, B. Ardanza, P. Nurden, and A.T. Nurden. 2004. Autologous platelets as a source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis 91: 4\u201315.","journal-title":"Thrombosis and Haemostasis"},{"key":"9716_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.exphem.2009.03.009","volume":"37","author":"J Villeneuve","year":"2009","unstructured":"Villeneuve, J., A. Block, M.C. Le Bousse-Kerdiles, S. Lepreux, P. Nurden, J. Ripoche, et al. 2009. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: A novel organization for these secreted proteins. Experimental Hematology 37: 849\u2013856.","journal-title":"Experimental Hematology"},{"key":"9716_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/ard.2003.011122","volume":"63","author":"K Yanaba","year":"2004","unstructured":"Yanaba, K., K. Takehara, and S. Sato. 2004. Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: Association with lower frequency of pulmonary fibrosis. Annals of the Rheumatic Diseases 63: 583\u2013587.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9716_CR20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1084\/jem.191.8.1413","volume":"191","author":"PS Frenette","year":"2000","unstructured":"Frenette, P.S., C.V. Denis, L. Weiss, K. Jurk, S. Subbarao, B. Kehrel, et al. 2000. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. Journal of Experimental Medicine 191: 1413\u20131422.","journal-title":"Journal of Experimental Medicine"},{"key":"9716_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ejcb.2010.12.002","volume":"90","author":"B Kasper","year":"2011","unstructured":"Kasper, B., and F. Petersen. 2011. Molecular pathways of platelet factor 4\/CXCL4 signaling. European Journal of Cell Biology 90: 521\u2013526.","journal-title":"European Journal of Cell Biology"},{"key":"9716_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1346-8138.1998.tb02385.x","volume":"25","author":"M Maeda","year":"1998","unstructured":"Maeda, M., H. Kachi, and S. Mori. 1998. Ultrastructural observation of platelets from patients with progressive systemic sclerosis (PSS). Journal of Dermatology 25: 222\u2013230.","journal-title":"Journal of Dermatology"},{"key":"9716_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/ard.2003.020040","volume":"64","author":"Y Allanore","year":"2005","unstructured":"Allanore, Y., D. Borderie, C. Meune, H. Lemarechal, S. Weber, O.G. Ekindjian, et al. 2005. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers. Annals of the Rheumatic Diseases 64: 481\u2013483.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9716_CR24","first-page":"514","volume":"31","author":"K Komura","year":"2004","unstructured":"Komura, K., S. Sato, M. Hasegawa, M. Fujimoto, and K. Takehara. 2004. Elevated circulating CD40L concentrations in patients with systemic sclerosis. Journal of Rheumatology 31: 514\u2013519.","journal-title":"Journal of Rheumatology"},{"key":"9716_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ard.55.2.122","volume":"55","author":"AL Herrick","year":"1996","unstructured":"Herrick, A.L., K. Illingworth, A. Blann, C.R. Hay, S. Hollis, and M.I. Jayson. 1996. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Annals of the Rheumatic Diseases 55: 122\u2013127.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9716_CR26","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.23735","volume":"58","author":"S Guiducci","year":"2008","unstructured":"Guiducci, S., J.H. Distler, A. Jungel, D. Huscher, L.C. Huber, B.A. Michel, et al. 2008. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism 58: 2845\u20132853.","journal-title":"Arthritis and Rheumatism"},{"key":"9716_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/157016109787354105","volume":"7","author":"C Fonseca","year":"2009","unstructured":"Fonseca, C., D. Abraham, and M. Ponticos. 2009. Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis. Current Vascular Pharmacology 7: 34\u201339.","journal-title":"Current Vascular Pharmacology"},{"key":"9716_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/030097401753180372","volume":"30","author":"F Silveri","year":"2001","unstructured":"Silveri, F., R. De Angelis, A. Poggi, S. Muti, G. Bonapace, F. Argentati, et al. 2001. Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis. Scandinavian Journal of Rheumatology 30: 290\u2013296.","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"9716_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1445-5994.2010.02399.x","volume":"42","author":"L Polidoro","year":"2012","unstructured":"Polidoro, L., R. Barnabei, P. Giorgini, L. Petrazzi, C. Ferri, and G. Properzi. 2012. Platelet activation in patients with the Raynaud's Phenomenon. Internal Medicine Journal 42: 531\u2013535.","journal-title":"Internal Medicine Journal"},{"key":"9716_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/hep.23435","volume":"51","author":"MM Zaldivar","year":"2010","unstructured":"Zaldivar, M.M., K. Pauels, P. von Hundelshausen, M.L. Berres, P. Schmitz, J. Bornemann, et al. 2010. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology 51: 1345\u20131353.","journal-title":"Hepatology"},{"key":"9716_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees, C., A. Akhmetshina, P. Zerr, N. Reich, K. Palumbo, A. Horn, et al. 2011. Platelet-derived serotonin links vascular disease and tissue fibrosis. Journal of Experimental Medicine 208: 961\u2013972.","journal-title":"Journal of Experimental Medicine"},{"key":"9716_CR32","first-page":"1801","volume":"35","author":"A Abou-Raya","year":"2008","unstructured":"Abou-Raya, A., S. Abou-Raya, and M. Helmii. 2008. Statins: Potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. Journal of Rheumatology 35: 1801\u20131808.","journal-title":"Journal of Rheumatology"},{"key":"9716_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/rheumatology\/ken310","volume":"47","author":"M Matucci-Cerinic","year":"2008","unstructured":"Matucci-Cerinic, M., and J.R. Seibold. 2008. Digital ulcers and outcomes assessment in scleroderma. Rheumatology (Oxford, England) 47: 46\u201347.","journal-title":"Rheumatology (Oxford, England)"},{"key":"9716_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.24537","volume":"61","author":"AE Hak","year":"2009","unstructured":"Hak, A.E., E.W. Karlson, D. Feskanich, M.J. Stampfer, and K.H. Costenbader. 2009. Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study. Arthritis and Rheumatism 61: 1396\u20131402.","journal-title":"Arthritis and Rheumatism"},{"key":"9716_CR35","doi-asserted-by":"publisher","unstructured":"Balbaloglu O, Korkmaz M, Yolcu S, Karaaslan F, Beceren NG. 2013. Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis. Platelets. doi:10.3109\/09537104.2013.776162","DOI":"10.3109\/09537104.2013.776162"},{"key":"9716_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","volume":"75","author":"B Kisacik","year":"2008","unstructured":"Kisacik, B., A. Tufan, U. Kalyoncu, O. Karadag, A. Akdogan, M.A. Ozturk, S. Kiraz, I. Ertenli, and M. Calguneri. 2008. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint, Bone, Spine 75: 291\u2013294.","journal-title":"Joint, Bone, Spine"},{"key":"9716_CR37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00296-009-1345-1","volume":"30","author":"AY Gasparyan","year":"2010","unstructured":"Gasparyan, A.Y., A. Sandoo, A. Stavropoulos-Kalinoglou, and G.D. Kitas. 2010. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-\u03b1 therapy. Rheumatology International 30: 1125\u20131129.","journal-title":"Rheumatology International"},{"key":"9716_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-642-71499-3_4","volume-title":"Prostacyclin and its stable analogue iloprost","author":"CS St\u00fcrzebecher","year":"1987","unstructured":"St\u00fcrzebecher, C.S. 1987. Effects of iloprost on platelet activation in vitro. In Prostacyclin and its stable analogue iloprost, ed. R.J. Gryglewski and G. Stock, 39\u201345. Berlin: Springer."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-013-9716-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9716-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T10:20:11Z","timestamp":1628072411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-013-9716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9716"],"URL":"https:\/\/doi.org\/10.1007\/s10753-013-9716-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,1]]},"assertion":[{"value":"1 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}